GlobeNewswire Inc.··DelveinsightOligonucleotide Boom: 200+ Companies Race to Launch 600+ Pipeline Drugs
Over 200 companies are developing 600+ oligonucleotide therapies, with major players advancing late-stage trials and securing significant funding.
AMGNLLYNVSBIIBIONS+3clinical trialsgene therapy